Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2S,3R,4S,5S)-2-methyl-5-(phenylamino)pyrrolidine-3,4-diol | inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides | Bos taurus | |
(2S,3S,4R,5S)-2-(1H-benzimidazol-2-yl)-5-methylpyrrolidine-3,4-diol | inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides | Bos taurus | |
(2S,3S,4R,5S)-2-[(biphenyl-4-ylamino)methyl]-5-methylpyrrolidine-3,4-diol | inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides | Bos taurus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bos taurus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
kidney | - |
Bos taurus | - |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00004 | - |
(2S,3S,4R,5S)-2-[(biphenyl-4-ylamino)methyl]-5-methylpyrrolidine-3,4-diol | - |
Bos taurus | |
0.00008 | - |
(2S,3S,4R,5S)-2-(1H-benzimidazol-2-yl)-5-methylpyrrolidine-3,4-diol | - |
Bos taurus | |
0.000237 | - |
(2S,3R,4S,5S)-2-methyl-5-(phenylamino)pyrrolidine-3,4-diol | - |
Bos taurus |